DANICA PINSON: Open Payments
NPI 1225514201 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,526 in 79 payments from 11 companies in 2025. Trend: 2023 $1,245 · 2024 $1,613 · 2025 $2,526
Food & beverage: $1,692Consulting: $750Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $1,158 |
| Madrigal Pharmaceuticals | 10 | $441 |
| Janssen Biotech, Inc. | 17 | $260 |
| Ardelyx, Inc. | 20 | $228 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Novo Nordisk Inc | 2 | $48 |
| PFIZER INC. | 2 | $40 |
| Celltrion USA Inc. | 1 | $22 |
| VIVUS LLC | 1 | $22 |
Products named: RINVOQ, REZDIFFRA, TREMFYA, IBSRELA, XIFAXAN, LINZESS, ENTYVIO, SKYRIZI.
Industry payments across GA — which companies pay providers there.
